PROVIDER PROFILE · NPI 1013685932

Avital GravanisPA-C

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

Beneficiaries

—

Total drug cost

$1K

Distinct drugs

Brand share

23.5%

Top prescribed drugs

QUALITY · MIPS · 2024

Final MIPS score

93.2

Quality

77.8

Cost

71.2

Improvement activities

40.0

Promoting interop.

98.0

Payment adjustment

0.77%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (3)

Hospital

Hospital

Hospital

CROSS-REFERENCE